As of May 31, 2026, the Company had an accumulated deficit of approximately $56.4 million. The Company has historically funded its operations primarily through the issuance of the Company's common stock, par value $0.001 per share ("Common Stock"). The Company also maintains access to additional liquidity through its revolving line of credit and delayed draw term loan facility, under which $5.0 million and $15.0 million, respectively, remained available as of May 31, 2026 (see Note 24, Credit Facility). The Company generated a net loss of $9.3 million and used $3.0 million of cash in operations for the six months ended May 31, 2026. The Company's future results will depend on its ability to continue generating sufficient revenue to fund operating expenses and to effectively market its products.